These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 21554566

  • 21. Age-related changes in melatonin levels in humans and its potential consequences for sleep disorders.
    Waldhauser F, Kovács J, Reiter E.
    Exp Gerontol; 1998; 33(7-8):759-72. PubMed ID: 9951620
    [Abstract] [Full Text] [Related]

  • 22. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.
    Wang-Weigand S, McCue M, Ogrinc F, Mini L.
    Curr Med Res Opin; 2009 May; 25(5):1209-13. PubMed ID: 19327100
    [Abstract] [Full Text] [Related]

  • 23. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
    Srinivasan V, Zakaria R, Othaman Z, Brzezinski A, Prasad A, Brown GM.
    CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
    [Abstract] [Full Text] [Related]

  • 24. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.
    Hardeland R.
    Neuropsychiatr Dis Treat; 2009 Mar; 5():341-54. PubMed ID: 19557144
    [Abstract] [Full Text] [Related]

  • 25. Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
    Nishimon S, Nishimon M, Nishino S.
    Expert Opin Pharmacother; 2019 Jun; 20(9):1065-1073. PubMed ID: 30990759
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G, Bedini A, Lucarini S, Mor M, Rivara S.
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
    [Abstract] [Full Text] [Related]

  • 27. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
    [Abstract] [Full Text] [Related]

  • 28. Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives.
    Comai S, Lopez-Canul M, De Gregorio D, Posner A, Ettaoussi M, Guarnieri FC, Gobbi G.
    Pharmacol Res; 2019 Jun; 144():343-356. PubMed ID: 31029764
    [Abstract] [Full Text] [Related]

  • 29. Recent progress in the development of agonists and antagonists for melatonin receptors.
    Zlotos DP.
    Curr Med Chem; 2012 Jun; 19(21):3532-49. PubMed ID: 22680635
    [Abstract] [Full Text] [Related]

  • 30. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR, Srinivasan V, Spence DW, Moscovitch A, Hardeland R, Brown GM, Cardinali DP.
    Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
    [Abstract] [Full Text] [Related]

  • 31. Tasimelteon for insomnia.
    Lankford DA.
    Expert Opin Investig Drugs; 2011 Jul; 20(7):987-93. PubMed ID: 21548834
    [Abstract] [Full Text] [Related]

  • 32. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
    Devi V, Shankar PK.
    J Postgrad Med; 2008 Jul; 54(1):45-8. PubMed ID: 18296808
    [Abstract] [Full Text] [Related]

  • 33. Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches.
    Hardeland R.
    Curr Pharm Des; 2016 Jul; 22(8):1086-101. PubMed ID: 25248806
    [Abstract] [Full Text] [Related]

  • 34. Ramelteon for the treatment of insomnia in menopausal women.
    Dobkin RD, Menza M, Bienfait KL, Allen LA, Marin H, Gara MA.
    Menopause Int; 2009 Mar; 15(1):13-8. PubMed ID: 19237617
    [Abstract] [Full Text] [Related]

  • 35. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis.
    Kuriyama A, Honda M, Hayashino Y.
    Sleep Med; 2014 Apr; 15(4):385-92. PubMed ID: 24656909
    [Abstract] [Full Text] [Related]

  • 36. Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat.
    Fisher SP, Sugden D.
    Neurosci Lett; 2009 Jun 26; 457(2):93-6. PubMed ID: 19429170
    [Abstract] [Full Text] [Related]

  • 37. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP, Davidson K, Kulla A, Sugden D.
    J Pineal Res; 2008 Sep 26; 45(2):125-32. PubMed ID: 18298466
    [Abstract] [Full Text] [Related]

  • 38. New and emerging pharmacotherapeutic approaches for insomnia.
    Neubauer DN.
    Int Rev Psychiatry; 2014 Apr 26; 26(2):214-24. PubMed ID: 24892896
    [Abstract] [Full Text] [Related]

  • 39. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].
    Quera-Salva MA, Claustrat B.
    Encephale; 2018 Dec 26; 44(6):548-557. PubMed ID: 30107892
    [Abstract] [Full Text] [Related]

  • 40. The efficacy of melatonin and melatonin agonists in insomnia - An umbrella review.
    Low TL, Choo FN, Tan SM.
    J Psychiatr Res; 2020 Feb 26; 121():10-23. PubMed ID: 31715492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.